The infusion of mutOSM-CD81-SEVs in ISO-treated animals also exerted a positive effect in cardiomyocytes, as the analysis of cardiac muscle fibers in control and mutOSM-CD81-SEV-treated animals revealed the capacity of these vesicles to prevent cardiac hypertrophy. The gene discussed is CD81; the disease is cardiac hypertrophy.